Tirone E. David再植入技术行主动脉瓣保留根部置换:单中心25年经验
该单中心回顾性研究纳入1993至2019年732例接受David主动脉瓣保留根部置换术的患者,平均年龄53±15岁,男性占71%。院内死亡3.8%,择期手术1.9%;术后96%患者主动脉瓣反流≤I°。1、5、10、15年生存率分别为93%、88%、77%、65%,免于瓣膜相关再手术率分别为97%、93%、88%、85%。
要点
- David手术围术期安全,择期院内死亡1.9%,总体3.8%。
- 术后96%患者主动脉瓣反流≤I°,瓣膜功能良好。
- 15年免于瓣膜相关再手术率85%,生存率65%。
核心结论
- David手术可极安全地实施,择期微创入路和急诊A型夹层均适用,长期临床结果优异且多数患者瓣膜功能持久。
研究设计与样本
- 单中心回顾性研究,1993至2019年共732例接受主动脉瓣保留根部再植入术的患者。
主要发现
- 平均年龄53±15岁,男性522例(71%),Marfan综合征117例(16%),二叶主动脉瓣81例(11%)。
- 手术指征为主动脉根部动脉瘤588例(80%),急性主动脉夹层144例(20%)。
- 微型胸骨切开74例(10%),直管移植物(David I)677例(92%),Valsalva移植物55例(8%),瓣叶成形83例(11%),合并心脏手术438例(60%)。
- 总体院内死亡3.8%(29例),择期手术1.9%(11例);术后超声心动图671例中647例(96%)主动脉瓣反流≤I°。
- 平均随访10±6.7年,共7307患者年;1、5、10、15年生存率分别为93%、88%、77%、65%,免于瓣膜相关再手术率分别为97%、93%、88%、85%。
关键数值与推荐
- Cox回归显示未来主动脉瓣反流或再手术的危险因素:年龄(OR=0.975,95%CI 0.955-0.995,P=0.016)、高脂血症(OR=1.980,95%CI 1.175-3.335,P=0.010)、术前左心室射血功能水平(OR=1.749,95%CI 1.024-2.987,P=0.041)、术后主动脉瓣反流程度(OR=1.880,95%CI 1.532-2.308,P≤0.001)。
临床怎么用
- David手术可用于择期微创入路及急诊A型主动脉夹层,围术期风险低,长期瓣膜功能满意。
- 术后主动脉瓣反流程度是再手术的重要预测因素,需密切随访超声心动图。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Tirone E. David described aortic valve-sparing root reimplantion (AVSRR) almost 30 years ago. At our centre, we adopted this operation in 1993, and since then, we have performed >700 operations over a time period of >25 years. In this report, we present our single-centre experience. METHODS: Between 1993 and 2019, a total of 732 patients underwent AVSRR at our centre. The mean age was 53 ± 15 and 522 (71%) were male. Marfan syndrome was present in 117 (16%) patients and bicuspid aortic valve in 81 (11%). The indication for surgery was aortic root aneurysm in 588 (80%) patients and acute aortic dissection in 144 (20%) patients. RESULTS: Mini-sternotomy was performed in 74 (10%) patients. A straight tube graft (David I) was used in 677 (92%) and a Valsalva-graft in 55 (8%) patients. Cusp plasty was done in 83 (11%) patients. Concomitant cardiac procedures were performed in 438 (60%) patients. Overall in-hospital mortality was 3.8% (n = 29) and 1.9% (n = 11) in elective cases. Postoperative echocardiography was available for 671 patients and showed aortic insufficiency (AI) ≤I° in 647 (96%) patients. The mean follow-up time was 10 ± 6.7 years and comprised a total of 7307 patient-years. The 1-, 5-, 10- and 15-year survival rates were: 93%, 88%, 77% and 65%, respectively. The rates for freedom from valve-related reoperation at 1, 5, 10 and 15 years after initial surgery were 97%, 93%, 88% and 85%, respectively. Cox regression analysis identified age [odds ratio (OR) = 0.975, 95% confidence interval (CI) = 0.955-0.995, P = 0.016], hyperlipidaemia (OR = 1.980, 95% CI = 1.175-3.335, P = 0.010), preoperative level of left ventricular ejection function (OR = 1.749, 95% CI = 1.024-2.987, P = 0.041) and postoperative degree of AI (OR = 1.880, 95% CI = 1.532-2.308, P ≤ 0.001) as risk factors for the future AI or reoperation. CONCLUSIONS: David procedure can be performed extremely safely, with low risks for perioperative morbidity and mortality, both in elective situations via minimally invasive access and in emergent settings for acute aortic type A dissection. Regarding long-term outcome, David's AVSRR seems to provide excellent clinical results and sustainable function of the aortic valve in the majority of patients almost 3 decades after its introduction.
引用
- Beckmann E, Martens A, Krüger H, et al. Aortic valve-sparing root replacement with Tirone E. David's reimplantation technique: single-centre 25-year experience. Eur J Cardiothorac Surg. 2021. PMID: 33778863. doi:10.1093/ejcts/ezab136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。